Impact of genetic markers on treatment of non-small cell lung cancer

Nicholas Lamparella, Amit Barochia, Salah Almokadem

Research output: Chapter in Book/Report/Conference proceedingChapter

6 Citations (Scopus)

Abstract

Non-small cell lung cancer represents a group of heterogeneous diseases. The last decade witnessed significant progress in improving our understanding of the biology of non-small cell lung cancer, which led to the identification of several genetic targets. Those genetic targets were utilized to explain clinical phenomena, such as the occurrence of non-small cell lung cancer in never-smokers, to predict response to conventional chemotherapy and biological agents, and to explain and predict resistance to therapy. The progress in the treatment of non-small cell lung cancer in the last few years was based on a new generation of population-enriched clinical trials that utilized genetic targets such as somatic EGFR mutations and ALK-EML4 mutations. In this review we will discuss the available information about the key genetic markers of non-small cell lung cancer and the pivotal clinical trials that validate the use of those genetic markers in non-small cell lung cancer patients.

Original languageEnglish (US)
Title of host publicationImpact of Genetic Targets on Cancer Therapy
EditorsWafik El-Deiry
Pages145-164
Number of pages20
DOIs
StatePublished - Feb 15 2013

Publication series

NameAdvances in Experimental Medicine and Biology
Volume779
ISSN (Print)0065-2598

Fingerprint

Genetic Markers
Non-Small Cell Lung Carcinoma
Cells
Therapeutics
Clinical Trials
Mutation
Chemotherapy
Biological Factors
Drug Therapy
Population

All Science Journal Classification (ASJC) codes

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Lamparella, N., Barochia, A., & Almokadem, S. (2013). Impact of genetic markers on treatment of non-small cell lung cancer. In W. El-Deiry (Ed.), Impact of Genetic Targets on Cancer Therapy (pp. 145-164). (Advances in Experimental Medicine and Biology; Vol. 779). https://doi.org/10.1007/978-1-4614-6176-0-6
Lamparella, Nicholas ; Barochia, Amit ; Almokadem, Salah. / Impact of genetic markers on treatment of non-small cell lung cancer. Impact of Genetic Targets on Cancer Therapy. editor / Wafik El-Deiry. 2013. pp. 145-164 (Advances in Experimental Medicine and Biology).
@inbook{abecfc791c314176bec6f8f6339a52bd,
title = "Impact of genetic markers on treatment of non-small cell lung cancer",
abstract = "Non-small cell lung cancer represents a group of heterogeneous diseases. The last decade witnessed significant progress in improving our understanding of the biology of non-small cell lung cancer, which led to the identification of several genetic targets. Those genetic targets were utilized to explain clinical phenomena, such as the occurrence of non-small cell lung cancer in never-smokers, to predict response to conventional chemotherapy and biological agents, and to explain and predict resistance to therapy. The progress in the treatment of non-small cell lung cancer in the last few years was based on a new generation of population-enriched clinical trials that utilized genetic targets such as somatic EGFR mutations and ALK-EML4 mutations. In this review we will discuss the available information about the key genetic markers of non-small cell lung cancer and the pivotal clinical trials that validate the use of those genetic markers in non-small cell lung cancer patients.",
author = "Nicholas Lamparella and Amit Barochia and Salah Almokadem",
year = "2013",
month = "2",
day = "15",
doi = "10.1007/978-1-4614-6176-0-6",
language = "English (US)",
isbn = "9781461461753",
series = "Advances in Experimental Medicine and Biology",
pages = "145--164",
editor = "Wafik El-Deiry",
booktitle = "Impact of Genetic Targets on Cancer Therapy",

}

Lamparella, N, Barochia, A & Almokadem, S 2013, Impact of genetic markers on treatment of non-small cell lung cancer. in W El-Deiry (ed.), Impact of Genetic Targets on Cancer Therapy. Advances in Experimental Medicine and Biology, vol. 779, pp. 145-164. https://doi.org/10.1007/978-1-4614-6176-0-6

Impact of genetic markers on treatment of non-small cell lung cancer. / Lamparella, Nicholas; Barochia, Amit; Almokadem, Salah.

Impact of Genetic Targets on Cancer Therapy. ed. / Wafik El-Deiry. 2013. p. 145-164 (Advances in Experimental Medicine and Biology; Vol. 779).

Research output: Chapter in Book/Report/Conference proceedingChapter

TY - CHAP

T1 - Impact of genetic markers on treatment of non-small cell lung cancer

AU - Lamparella, Nicholas

AU - Barochia, Amit

AU - Almokadem, Salah

PY - 2013/2/15

Y1 - 2013/2/15

N2 - Non-small cell lung cancer represents a group of heterogeneous diseases. The last decade witnessed significant progress in improving our understanding of the biology of non-small cell lung cancer, which led to the identification of several genetic targets. Those genetic targets were utilized to explain clinical phenomena, such as the occurrence of non-small cell lung cancer in never-smokers, to predict response to conventional chemotherapy and biological agents, and to explain and predict resistance to therapy. The progress in the treatment of non-small cell lung cancer in the last few years was based on a new generation of population-enriched clinical trials that utilized genetic targets such as somatic EGFR mutations and ALK-EML4 mutations. In this review we will discuss the available information about the key genetic markers of non-small cell lung cancer and the pivotal clinical trials that validate the use of those genetic markers in non-small cell lung cancer patients.

AB - Non-small cell lung cancer represents a group of heterogeneous diseases. The last decade witnessed significant progress in improving our understanding of the biology of non-small cell lung cancer, which led to the identification of several genetic targets. Those genetic targets were utilized to explain clinical phenomena, such as the occurrence of non-small cell lung cancer in never-smokers, to predict response to conventional chemotherapy and biological agents, and to explain and predict resistance to therapy. The progress in the treatment of non-small cell lung cancer in the last few years was based on a new generation of population-enriched clinical trials that utilized genetic targets such as somatic EGFR mutations and ALK-EML4 mutations. In this review we will discuss the available information about the key genetic markers of non-small cell lung cancer and the pivotal clinical trials that validate the use of those genetic markers in non-small cell lung cancer patients.

UR - http://www.scopus.com/inward/record.url?scp=84873591227&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84873591227&partnerID=8YFLogxK

U2 - 10.1007/978-1-4614-6176-0-6

DO - 10.1007/978-1-4614-6176-0-6

M3 - Chapter

C2 - 23288638

AN - SCOPUS:84873591227

SN - 9781461461753

T3 - Advances in Experimental Medicine and Biology

SP - 145

EP - 164

BT - Impact of Genetic Targets on Cancer Therapy

A2 - El-Deiry, Wafik

ER -

Lamparella N, Barochia A, Almokadem S. Impact of genetic markers on treatment of non-small cell lung cancer. In El-Deiry W, editor, Impact of Genetic Targets on Cancer Therapy. 2013. p. 145-164. (Advances in Experimental Medicine and Biology). https://doi.org/10.1007/978-1-4614-6176-0-6